Gene Expression Changes Induced by Genistein in the Prostate Cancer Cell Line LNCaP
暂无分享,去创建一个
R. Tibshirani | D. Sahoo | J. Brooks | D. Dill | S. Bhamre | Suvarna Bhamre
[1] J. Ampuero,et al. Sentinel Surveillance of Influenza-Like-Illness in Two Cities of the Tropical Country of Ecuador: 2006–2010 , 2011, PloS one.
[2] Michael J. Schlicht,et al. Use of cross species genomic profiling identifies pathways and genes differentially regulated in prostate cancer cells treated with soy protein isolates or purified genistein. , 2010, Cancer genomics & proteomics.
[3] Jun Wang,et al. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag rats , 2009, The Prostate.
[4] Ximing J. Yang,et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. , 2009, Journal of the National Cancer Institute.
[5] Johann S de Bono,et al. Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer , 2009, Clinical Cancer Research.
[6] R. Levy,et al. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. , 2009, Nutrition reviews.
[7] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[8] J. Brooks,et al. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation , 2009, The Prostate.
[9] J. Brooks,et al. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients , 2009, International journal of cancer.
[10] R. Tibshirani,et al. Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells , 2009, The Prostate.
[11] M. Inoue,et al. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] F. Saatcioglu,et al. Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells. , 2008, Oncology reports.
[13] M. Chau,et al. Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. , 2007, Carcinogenesis.
[14] P. Banerjee,et al. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. , 2007, Carcinogenesis.
[15] Debashis Sahoo,et al. Extracting binary signals from microarray time-course data , 2007, Nucleic acids research.
[16] J. Brooks,et al. A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells , 2007, Nucleic acids research.
[17] C. Tepper,et al. GCP‐mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor‐dependent and ‐independent mechanisms , 2007, The Prostate.
[18] H. Baker,et al. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells. , 2007, Journal of NutriLife.
[19] M. Inoue,et al. Soy Product and Isoflavone Consumption in Relation to Prostate Cancer in Japanese Men , 2007, Cancer Epidemiology Biomarkers & Prevention.
[20] J. Brooks,et al. Selenomethionine induced transcriptional programs in human prostate cancer cells. , 2007, The Journal of urology.
[21] Yoko Takahashi,et al. Molecular signatures of soy‐derived phytochemicals in androgen‐responsive prostate cancer cells: A comparison study using DNA microarray , 2006, Molecular carcinogenesis.
[22] I. Rowland,et al. Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress. , 2006, Carcinogenesis.
[23] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[24] J. Brooks,et al. Resveratrol-Induced Gene Expression Profiles in Human Prostate Cancer Cells , 2005, Cancer Epidemiology Biomarkers & Prevention.
[25] Yoko Takahashi,et al. Using DNA microarray analyses to elucidate the effects of genistein in androgen‐responsive prostate cancer cells: Identification of novel targets , 2004, Molecular carcinogenesis.
[26] J. Brooks,et al. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[27] J. Brooks,et al. Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays , 2004, The Prostate.
[28] Zhengxin Wang,et al. Modulation of androgen receptor‐dependent transcription by resveratrol and genistein in prostate cancer cells , 2004, The Prostate.
[29] R. Tibshirani,et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] David Botstein,et al. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. , 2003, Molecular biology of the cell.
[31] Yiwei Li,et al. Gene expression profiles of genistein-treated PC3 prostate cancer cells. , 2002, The Journal of nutrition.
[32] L. A. Nelson,et al. Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[33] Robert Tibshirani,et al. Transcriptional programs activated by exposure of human prostate cancer cells to androgen , 2002, Genome Biology.
[34] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[35] Ken Itoh,et al. Enhanced Expression of the Transcription Factor Nrf2 by Cancer Chemopreventive Agents: Role of Antioxidant Response Element-Like Sequences in the nrf2 Promoter , 2002, Molecular and Cellular Biology.
[36] J. Brooks,et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. , 2001, The American journal of pathology.
[37] J. Brooks,et al. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[38] C. Lamartiniere,et al. The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory sex gland carcinoma. , 1999, Cancer letters.
[39] B. Jacobsen,et al. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States) , 1998, Cancer Causes & Control.
[40] J. Brooks,et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[41] J. Fahey,et al. Chemoprotection against cancer by phase 2 enzyme induction. , 1995, Toxicology letters.
[42] G. Kelloff,et al. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. , 1995, Cancer research.
[43] J. Brooks,et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] H. Adlercreutz,et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Santamaria,et al. Rapid detection of inducers of enzymes that protect against carcinogens. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Pinski,et al. Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells , 2009, The Prostate.
[47] H. Adlercreutz,et al. Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation , 2006, The Prostate.
[48] David Botstein,et al. The Stanford Microarray Database , 2001, Nucleic Acids Res..
[49] F. Sarkar,et al. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. , 1998, Nutrition and cancer.
[50] S. R. Spencer,et al. The electrophile counterattack response: protection against neoplasia and toxicity. , 1993, Advances in enzyme regulation.
[51] W. Haenszel,et al. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. , 1968, Journal of the National Cancer Institute.